1-4 of 4
Jong Seok Lee, MD
Close
Sort by
Journal Articles

Ifosfamide, Methotrexate, Etoposide, and Prednisolone (IMEP) Plus L-Asparaginase As a First-Line Therapy Improves Outcomes In Stage III/IV NK/T-Cell Lymphoma, Nasal Type (NTCL)

Miso Kim, MD, Ki Hwan Kim, MD, Bhumsuk Keam, MD, Se-Hoon Lee, MD, PhD, Dong-Wan Kim, MD, PhD, Jong Seok Lee, MD, PhD, Dae Seog Heo, MD, PhD, Tae Min Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4347.
https://doi.org/10.1182/blood.V122.21.4347.4347
Published: 2013
Journal Articles

Pharmacokinetics and Tolerability of Intravenous Busulfan in Hematopoietic Stem Cell Transplantation.

Sung-Soo Yoon, MD, PhD, Yo-Han Cho, MD, Hyun-Ae Lim, Inho Kim, MD, Soo-Mee Bang, MD, Jong Seok Lee, MD, Seonyang Park, MD, PhD, Byoung KooK Kim, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5249.
https://doi.org/10.1182/blood.V108.11.5249.5249
Published: 2006
Journal Articles

Novel Synthetic Histone Deacetylase Inhibitor (SK-7041) Potently Inhibits Proliferation in Acute Myeloid Leukemia Cell Lines.

Young-Ju Kim, MS, Susan Guo, BA, Ju Won Park, BA, Eun Kyung Bae, MS, Kwang-Sung Ahn, PhD, Inho Kim, MD, PhD, Jong-Seok Lee, MD, PhD, Young Yiul Lee, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Sung-Soo Yoon, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 4407.
https://doi.org/10.1182/blood.V106.11.4407.4407
Published: 2005
Journal Articles

Effect of the Combination of Imatinib Mesylate (Glivec) and Curcumin in Chronicm Myeloid Leukemia Cell Line.

Young-Ju Kim, BS, Yong-Hee Choi, MS, Chang Up Kim, MD, Eun Kyung Bae, MS, Byung-Su Kim, MD, Kwang-Sung Ahn, Ph.D, Jong-Seok Lee, MD, Seonyang Park, MD, Byoung Kook Kim, MD, Sung-Soo Yoon, M.D, Ph.D
Journal: Blood
Blood (2004) 104 (11): 4685.
https://doi.org/10.1182/blood.V104.11.4685.4685
Published: 2004